Adverse Effects
Self-Care Toolkits Ease Negative PostSurgery Experiences for Patients With Breast Cancer
October 10, 2018Self-care toolkits were found to reduce pain and other negative postsurgical experiences for women undergoing surgical procedures for breast cancer.
Assessment Tool for Immunotherapy Side Effects
October 04, 2018My patient is receiving immunotherapy. What is the best tool for assessing side effects?
Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients
October 03, 2018A review of how emotions, social perceptions, and physical effects influence coping skills for men with prostate cancer.
CNS Tumors in Childhood: Predicting Successful Independence in Adult Life
October 01, 2018Researchers at St Jude Children's Research Hospital sought to determine what indicators in survivors of CNS tumors can predict the survivor's ability to live independently as an adult.
Infections in Primary Immune Thrombocytopenia Associated With Low Platelet Count
September 26, 2018A retrospective study of platelet- and infection-related data from patients with ITP revealed the influence platelet levels have on infections as well as efficacy of transfusions.
Estimating Quality of Life Based on Cumulative Drug Toxicity in Colorectal Cancer
September 24, 2018Results of a study in which more than 100 patients with metastatic colorectal cancer completed EORTC-QLQ-C30 suggests an association between assessment of cumulative drug toxicities and predictions of quality of life for patients undergoing first-line chemotherapy for the disease.
Late Lower Cranial Neuropathy Worsens Symptom Burden in Oropharyngeal Cancer Survivors
September 10, 2018Researchers conducted a cross-sectional study to determine the incidence and effect of late lower cranial neuropathies on survivors of oropharyngeal cancers.
SD-101 May Enhance the Effectiveness of Immunotherapy in Melanoma
August 31, 2018In this phase 1b study, researchers evaluated the efficacy of immunotherapy with pembrolizumab to treat advanced melanoma.
Nonmyeloablative/Reduced-Intensity Conditioning May Reduce Mucositis in HCT
August 16, 2018Researchers sought to determine if NMA or reduced-intensity conditioning with busulfan improved severity/duration of oral mucositis compared with myeloablative conditioning in patients with hematologic cancer undergoing HCT.
FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
August 14, 2018The manufacturer of daratumumab, a CD38-directed antibody for the treatment of multiple myeloma, has submitted a sBLA and a type II variation to the US FDA and European Medicines Agency, respectively, for approval of a split dosing regimen.
8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
August 14, 2018In an open-label study, researchers sought to determine the optimal amount of bed rest after intrathecal chemotherapy for patients with hematologic cancers.
Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma
August 10, 2018In a systematic review, researchers explored the financial burden of treating grade 3 to 4 adverse events associated with melanoma and its treatment.
Healthcare Use, Economic Burden Greater With Cancer-Related Opioid-Induced Constipation
August 03, 2018Use of opioids to manage cancer-related pain may have adverse effects of its own that can have a significant impact on healthcare use among patients with cancer.
Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
July 18, 2018In an analysis of 11 studies, researchers investigated whether the benefits of carfilzomib for multiple myeloma outweigh the cardiovascular risks. However, the researchers recommend careful monitoring and management of blood pressure and volume status as good clinical practice, regardless.
Genetic Link Between Depression and Breast Cancer Remains Unclear
July 17, 2018In this study, researchers sought to determine if a genetic predisposition to depression exists in some patients with breast cancer and how to identify it.
Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer
July 06, 2018In a randomized study, researchers sought to determine the effect of IV injections of coix seed oil, a Chinese CAM, on pain and quality of life measures for patients with advanced cancer.
Handgrip Force May Provide Objective Evaluation of Cancer-Related Fatigue
July 05, 2018Researchers sought to determine if handgrip force could provide objective measures of CRF in patients with cancer.
CALM: A Depression Intervention for Cancer Patients at the End of Life
July 03, 2018The effectiveness of a novel intervention intended to reduce and/or prevent depression in patients with advanced cancer at the end of life was investigated in a randomized study with more than 300 patients.
Live or Online Mindfulness-Based Cognitive Therapy Reduced Cancer-Related Psychological Distress
July 02, 2018Mindfulness-based interventions are proven effective in helping patients with cancer manage distress and other psychological symptoms. In this study, researchers sought to determine if Internet-based MBCT can be as effective as face-to-face interventions.
PTSD May Increase Symptom Burden in Patients With Cancer
July 02, 2018Post-traumatic stress symptoms are linked to a greater symptom burden in hospitalized cancer patients.
Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
June 29, 2018In this retrospective study, researchers sought to determine the effectiveness of fentanyl for dyspnea in dying patients with advanced cancer.
Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer
June 28, 2018In a retrospective study, researchers used established tools to measure the nutritional status of patients with head and neck cancer before, immediately after, and at 2 follow-up points after radiotherapy.
Ixazomib, Lenalidomide, Dexamethasone Effective But Increases Toxicity in Multiple Myeloma
June 27, 2018Three-drug regimen twice a week achieved good response and long-term outcomes in patients with newly diagnosed multiple myeloma; however, regimen has higher toxicity than once weekly dose.
Low-Dose Dasatinib for Chronic-Phase CML Safe, Effective With Fewer Adverse Events
June 25, 2018In this study, researchers assigned 75 patients with newly diagnosed Philadelphia chromosome (Ph)-positive CML-CP to receive dasatinib 50 mg once daily.
Childhood Neuroblastoma Survivors at Risk for Psych Impairment
June 19, 2018Psychological impairment seen particularly in survivors with chronic health conditions.
Navigating the Benefits and Challenges of Immunotherapy
June 15, 2018A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.
Muscle Loss Not Always Correlated With Loss of Function, Strength in Cancer Cachexia
June 12, 2018Interventions specifically designed to target cachexia in patients with thoracic or gastrointestinal cancer and established cachexia were effective in helping patients preserve functional stability and rehabilitation potential.
Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years
June 11, 2018A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.
Primary Prophylaxis Key in Reducing Febrile Neutropenia in Early Breast Cancer
June 07, 2018In a retrospective study, researchers investigated the effect of primary prophylaxis on incidence of febrile neutropenia in patients with early stage breast cancer.
Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy
June 06, 2018Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.
Sign Up for Free e-newsletters
ONA Articles
- Aggressive EOL Care Negatively Impacts Care Quality, Health Costs in Metastatic Lung Cancer
- Navigation at the End of Therapy: A Crucial Transition in Lymphoma Treatment
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Risk of Relapse Up for Young Adults With Leukemia
- FDA Approves HPV Vaccine for People Through Age 45
- Tandem Autologous-Allogenic HCT Offers Long-Term Remission in Multiple Myeloma
- Tool Addresses Well-being of Informal Caregivers of Patients With Cancer
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Aggressive EOL Care Negatively Impacts Care Quality, Health Costs in Metastatic Lung Cancer
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Myelofibrosis: From Diagnosis to Early Intervention
- FDA Approves HPV Vaccine for People Through Age 45
- Treatment Strategies and Predicting Prognoses in Elderly Patients With Breast Cancer
- Weight Loss May Cut Breast Cancer Risk in Postmenopausal Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |